Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF606 antisense RNA 1 (ZNF606-AS1) is a long non-coding RNA gene expressed as an antisense transcript to the protein-coding ZNF606 gene. Antisense lncRNAs as a class are known to regulate gene expression via epigenetic, transcriptional, or post-transcriptional mechanisms, typically by recruiting chromatin modifiers, interacting with transcription factors, or stabilizing/destabilizing sense mRNAs[1][2][3]. ZNF606-AS1 itself is uncharacterized in the literature regarding its specific biological roles, disease relevance, druggability, or clinical application. Its molecular identity places it in the growing family of regulatory lncRNAs with emerging importance in gene regulation and, occasionally, human disease, although direct evidence for ZNF606-AS1 is absent. ZNF606-AS1 is a non-protein-coding RNA, not a classical therapeutic target. It belongs to the family of antisense lncRNAs, which regulate gene expression but are not yet themselves directly linked to specific biological functions, disease roles, or pharmacological interventions[2][3]. There are no interacting drugs, established biomarkers, or safety concerns. The gene is accurately named and classified, but its function remains unstudied.
Not applicable. As no drugs target ZNF606-AS1, mechanism of action is undetermined. In principle, antisense lncRNAs can be targeted by synthetic antisense oligonucleotides (ASOs) for knockdown or modulation[3]. This is a general class-based inference, not validated for ZNF606-AS1 specifically.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZNF606 antisense RNA 1 (ZNF606-AS1).